Tag: MIT

New genes

Agricultural biotechnology giant Monsanto agreed in September to a global non-exclusive licensing agreement with the Broad Institute of MIT and Harvard to use the ground-breaking CRISPR-Cas gene-editing tool.

The St. Louis, Missouri-based company, which is in the midst of a merger with Germany’s Bayer under regulatory review, plans to use the technology for agricultural purposes. “Genome-editing techniques present precise ways to dramatically improve the scale and discovery efficiency of new research that can improve human health and global agriculture,” said Issi Rozen, chief business officer of the Broad Institute. “We are encouraged to see these tools being used to help deliver responsible solutions to help farmers meet the demands of our growing population.”